Nu Skin is about to release earnings results. They are so closely peered and compared to Herbalife it is becoming increasing difficult to analyse Nu Skin without automatic comparison rightly or wrongly to Herbalife. Multi-level companies have difficulty sustaining themselves in the long run. Nu Skin cannot be a core holding in anyones portfolio.
George Gutowski writes from a caveat emptor perspective.